Hepatocellular carcinoma (HCC) used to be considered as a rare disease. Though, the increasing numbers of chronic HCC carriers in the U.S. and later increased incidences of HCC seen in most large medical centers means that it is no more an uncommon disease for oncologists or gastroenterologists to meet and its incidence and epidemiology are changing. During this stimulating time in the field of HCC basic science and clinical management, many modifications are simultaneously occurring at numerous levels of our understanding and management of the disease. Unexpectedly, there are several new choices of therapy to provide patients. Hepatocellular Carcinoma, 3rd edition, (PDF) addresses this rapidly-changing disease and gives the reader a clearer understanding of the many mechanisms engaged in carcinogenesis of the liver. This detailed and comprehensive review of how to diagnose and treat hepatocellular carcinoma is written by international experts in the field, including both clinical treatment choices and the basic science causing HCC development. Enhanced and updated from the last edition in 2009, Hepatocellular Carcinoma 3e includes 12 new chapters including a discussion of molecular markers, microenvironment, heterogeneity, molecular hepatocarcinogenesis, the new and exciting contributions of immunotherapy, and updates on the main effective hepatitis therapies that will change HCC incidence and possibly also the therapy. This cutting-edge text is an essential resource and must-have for today’s hepatologists and surgical and medical oncologists.
“This is a very well-written ebook and should be a good reference book for those who see patients with HCC..” — Practical Gastroenterology
“A really helpful tool for both surgeons and physicians with a specific interest in the management of patients with HCC.” — Digestive and Liver Disease
NOTE: The product only includes the ebook, Hepatocellular Carcinoma: Diagnosis and Treatment, 3rd Edition in PDF. No access codes are included.